Cancer
AAMDS webinar for patients: Understanding the overlap between MDS and MPNs
May 15, 2020
Ruben Mesa, M.D., FACP, was the featured speaker during a webinar for patients sponsored by the Aplastic Anemia & MDS International Foundation. Dr. Mesa discusses the overlap between MDS (myelodysplastic sydromes) and MPNs (myeloproliferative neoplasms), including diagnosis and treatment options and the latest in clinical trials. He also provides an update on the impact of […]
Targeted Oncology: Investigators study JAK inhibitors in patients with myelofibrosis
May 12, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, is featured in this Targeted Oncology video discussing treatment for myelofibrosis. Read and watch the story.
PSA: Cancer prevention and screening during the COVID-19 pandemic
May 7, 2020
Ruben Mesa, M.D., director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson, asks that the public keep their cancer screenings, tests and treatments during this time.
Fox 29: New study sheds light into COVID-19 and cancer patients
April 29, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, comments on a new study released that shows how COVID-19 impacts cancer patients. Read and watch the full story.
The Bloodline with LLS: What blood cancer patients need to know about COVID-19
April 24, 2020
Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, is a guest on the Leukemia and Lymphoma Society’s podcast “The Bloodline”.
Conversation with the Cancer Letter: As COVID-19 peaks in San Antonio, Ruben Mesa predicts gradual reopening
April 24, 2020
Ruben A. Mesa, M.D., FACP, director of the Mays Cancer Center, discusses social distancing and the gradual reopening efforts in San Antonio during the COVID-19 pandemic.